First Cdc7 kinase inhibitors: Pyrrolopyridinones as potent and orally active antitumor agents. 2. lead discovery.

[摘要]：On page 293, the Author line is incorrect due to incorrect affiliation superscript symbols; the correct symbols and versions of the Author and Affiliation lines are given.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内